TRANSDERMALES PFLASTER

European patent · EP3932489 · Deleted

Register entry

Publication number
EP3932489
Application number
EP20762445
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 21, 2020
Published
Jan 5, 2022
Granted
Oct 25, 2023
Deleted
Sep 24, 2024
Reason
Annual fee unpaid
IPC classes
A61K 9/70 (2006.01)
A61P 29/00 (2006.01)
A61K 47/20 (2006.01)
A61K 47/32 (2006.01)
A61K 31/196 (2006.01)
Priority
JP 2019034363 27.02.2019
PCT application
PCT/JP2020/007182 21.02.2020
PCT publication
WO2020/175395 03.09.2020
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 24, 2024

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    24.09.2024
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 24.09.2024

  2. Sep 4, 2024

    Change

    Published in Swissreg on 04.09.2024

  3. Oct 25, 2023

    Granted

    Published in Swissreg on 25.10.2023

Parties

Holder

Hisamitsu Pharmaceutical Co. Inc.

Hisamitsu Pharmaceutical Co., Inc.

408, Tashirodaikan-machi, Tosu-shi, Saga 841-0017, JP

Inventor

KURITA, Hisakazu

Tosu-shi, Saga 841-0017, JP

KAMAKURA, Naoto

Tosu-shi, Saga 841-0017, JP

TAKEUCHI, Akio

Tosu-shi, Saga 841-0017, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.